China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
35.4625
51.82
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Operating Margin
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | CN |
Market Cap | 58.7B CNY |
Operating Margin |
17%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Operating Margin |
-83%
|
Country | US |
Market Cap | 710.5B USD |
Operating Margin |
35%
|
Country | UK |
Market Cap | 440.4B GBP |
Operating Margin |
3%
|
Country | DK |
Market Cap | 3.3T DKK |
Operating Margin |
44%
|
Country | US |
Market Cap | 373.5B USD |
Operating Margin |
28%
|
Country | US |
Market Cap | 251.1B USD |
Operating Margin |
34%
|
Country | CH |
Market Cap | 202.7B CHF |
Operating Margin |
32%
|
Country | CH |
Market Cap | 183.3B CHF |
Operating Margin |
31%
|
Country | UK |
Market Cap | 162.4B GBP |
Operating Margin |
21%
|
Country | IE |
Market Cap | 146B USD |
Operating Margin |
11%
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Glance View
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., a leading player in the healthcare sector, has carved a distinguished path through its commitment to innovation and quality. Established in 1992, the company has grown into a comprehensive healthcare provider with a diverse product portfolio that includes traditional Chinese medicine, over-the-counter drugs, and prescription medications. Leveraging its strong distribution network and extensive research and development capabilities, Sanjiu has positioned itself as a trusted brand among consumers and healthcare professionals alike. As the Chinese healthcare market continues to expand, fueled by a growing middle class and increasing health awareness, Sanjiu is well-poised to capitalize on these trends, driving both revenue growth and market share expansion. An investor looking into China Resources Sanjiu will find a company that not only maintains a robust financial foundation but also demonstrates an unwavering focus on sustainable practices and innovation. The company’s strategic partnerships and investments in modern technology, including digital health and telemedicine, further amplify its competitive edge. With a proactive approach to meeting evolving healthcare demands and an eye on regulatory developments, Sanjiu is not just a health-focused enterprise but a forward-thinking entity that embraces change in a dynamic industry. By combining traditional wisdom with modern methodologies, China Resources Sanjiu stands at the intersection of heritage and innovation, offering promising avenues for long-term growth and investor confidence.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on China Resources Sanjiu Medical & Pharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 17%.